comparemela.com

Latest Breaking News On - New jersey based catalent - Page 3 : comparemela.com

Catalent to acquire gummy maker with Indiana presence

Catalent to acquire gummy maker with Indiana presence
wishtv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wishtv.com Daily Mail and Mail on Sunday newspapers.

J&J coronavirus vaccine shipments halted due to ingredient MIX-UP during production

https://www.afinalwarning.com/508309.html (Natural News) Fifteen million doses of the Johnson & Johnson Wuhan coronavirus vaccine were ruined as a result of the wrong ingredient being added during production. The incident occurred in a factory in west Baltimore which federal authorities flagged for multiple violations. Because of the mishap, delays have been anticipated in the federal government’s vaccine rollout. A government official said the Department of Health and Human Services (HHS) discovered that Emergent BioSolutions ruined the 15 million doses by adding the wrong ingredient. The company’s Bayview facility in Baltimore is also producing AstraZeneca vaccines. Unfortunately, workers at Emergent accidentally included an ingredient meant for the AstraZeneca jabs in a batch of J&J vaccines.

Catalent boosting Moderna vaccine production

by: Alex Brown, Inside INdiana Business Posted: Apr 6, 2021 / 11:35 AM EST BLOOMINGTON, Ind. (Inside INdiana Business) New Jersey-based Catalent Inc. (NYSE: CTLT) is ramping up production of the Moderna Inc. (Nasdaq: MRNA) COVID-19 vaccine at its facility in Bloomington.  The Wall Street Journal reports the pharmaceutical company has agreed to increase efforts to produce about 400 vials per minute. Catalent plans to move the manufacturing of the vaccine to its new, high-speed vial filling line in Bloomington, plans for which were announced in September. The company plans to begin shipping the new doses next month, according to the publication. The Bloomington facility provides fill-finish manufacturing of the Moderna vaccine, which involves vial filling and packaging. The new production line will allow Catalent to fill an additional 80 million vials per year. 

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.